Serine biosynthesis is a metabolic vulnerability in IDH2-driven breast cancer progression. Barnabas GD, Sang Lee J, Shami T, Harel M, et al. Cancer Res 2021 Jan 26. pii: 0008-5472.CAN-19-3020.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Barnabas GD, Sang Lee J, Shami T, Harel M, et al. Serine biosynthesis is a metabolic vulnerability in IDH2-driven breast cancer progression. Cancer Res 2021 Jan 26. pii: 0008-5472.CAN-19-3020.
PMID: 33500247